Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alleance (Atropine 0.01%) for Myopia Progression in Children
NCT06389110Phase 3Recruiting
- Sponsor
- Laboratorios Sophia
- Start
- Mar 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Laboratorios Sophia. Started Mar 2025; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06389110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06389110.